Almirall, S.A. (BME:ALM)
Spain · Delayed Price · Currency is EUR 10.24
-0.34 (-3.21%)
Aug 1, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Commercialization through Own Network | 708.64M | Log In | Log In | Log In | Log In | Upgrade |
Commercialization through Own Network Growth | 7.64% | Log In | Log In | Log In | Log In | Upgrade |
Commercialization through Licensees | 88.22M | Log In | Log In | Log In | Log In | Upgrade |
Commercialization through Licensees Growth | 1.97% | Log In | Log In | Log In | Log In | Upgrade |
Dermatology in the United States | 57.49M | Log In | Log In | Log In | Log In | Upgrade |
Dermatology in the United States Growth | -22.50% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Management and Results Not Assigned to Other Segments | 40.18M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Management and Results Not Assigned to Other Segments Growth | -9.15% | Log In | Log In | Log In | Log In | Upgrade |
Research and Development Activity | - | Log In | Log In | Log In | Log In | Upgrade |
Research and Development Activity Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Spain | 296.92M | Log In | Log In | Log In | Log In | Upgrade |
Spain Growth | 8.42% | Log In | Log In | Log In | Log In | Upgrade |
Germany | 217.58M | Log In | Log In | Log In | Log In | Upgrade |
Germany Growth | 6.41% | Log In | Log In | Log In | Log In | Upgrade |
Europe and the Middle East | 128.65M | Log In | Log In | Log In | Log In | Upgrade |
Europe and the Middle East Growth | 34.82% | Log In | Log In | Log In | Log In | Upgrade |
Italy | 74.83M | Log In | Log In | Log In | Log In | Upgrade |
Italy Growth | 22.51% | Log In | Log In | Log In | Log In | Upgrade |
United States | 57.49M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | -22.50% | Log In | Log In | Log In | Log In | Upgrade |
America, Asia and Africa | 48.55M | Log In | Log In | Log In | Log In | Upgrade |
America, Asia and Africa Growth | -6.61% | Log In | Log In | Log In | Log In | Upgrade |
France | 42.71M | Log In | Log In | Log In | Log In | Upgrade |
France Growth | 21.32% | Log In | Log In | Log In | Log In | Upgrade |
United Kingdom | 27.80M | Log In | Log In | Log In | Log In | Upgrade |
United Kingdom Growth | 21.78% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Management and Revenue Not Allocated to Other Segments | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Management and Revenue Not Allocated to Other Segments Growth | - | Log In | Log In | Log In | Log In | Upgrade |